Azevan Pharmaceuticals, Inc.

Azevan Pharmaceuticals, Inc. (Azevan or the Company) is developing novel therapeutics for the treatment of disorders of stress, mood, and behavior. The Company leverages its expertise in behavioral neurobiology with its proprietary chemistry platform targeting G-protein coupled receptors (GPCRs) to create drug candidates. Azevan’s first series of clinical candidates selectively block the effects of arginine vasopressin (AVP), which is involved in the pathophysiology of various conditions including stress-related affective illness, impulsivity/inappropriate aggression, and menstrual-related disorders.
The value proposition for Azevan lies in its strong preclinical pipeline, the diverse indications and significant potential markets for selective vasopressin antagonists, and the flexibility of its proprietary chemistry that allows targeting of additional high value G-protein coupled receptors.

Contact Details: 115 Research Drive Bethlehem Pennsylvania 18015 United States of America Tel: (610) 419 1057 Fax: (610) 861 8247 Email: WWW: www.azevan.com/

Loading...

BioNews Results for Azevan Pharmaceuticals, Inc.:
Auxilium Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 4:32AM Matching: pharmaceuticals inc
BioSante Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 4:03AM Matching: pharmaceuticals inc
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	Dallas Business Chronicle:  Nov 16 2009 3:33AM Matching: pharmaceuticals inc
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	Kansas City Business Journal:  Nov 16 2009 3:25AM Matching: pharmaceuticals inc
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Resu	South Florida Business Journal:  Nov 16 2009 3:23AM Matching: pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Azevan Pharmaceuticals, Inc. news.

Azevan Pharmaceuticals, Inc. Patents:
US Patent No.	Title
7268125	.beta.-lactamyl vasopressin V.sub.1a antagonists
7119083	.beta.-Lactamyl vasopressin V.sub.1a Antagonists

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 550 times since April 2007, the link to the organisation's website has been followed 76 times

Recent Search Terms used to find this page: Azevan Pharmaceuticals Inc. | azevan pharmaceuticals | azevan pharmaceuticals | Azevan | Azevan Pharmaceuticals Inc. | Azevan Pharmaceuticals | Azevan Pharmaceuticals | value proposition for pharmaceuticals | azevan | Search Azevan Pharmaceuticals | .

Search for more companies in Bethlehem

Search for more companies in Pennsylvania

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Azevan Pharmaceuticals, Inc.